Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
-
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
-
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
-
Biotechnology | Environmental | Genomics | Life Science History | Medicine | Non-Profit Research | Pharmaceutical
Earth Microbiome Project scientists announced unprecedented catalog of microbial life on planet Earth
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
-
The Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded
In 2016, the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded with a $1 billion…
-
Genentech drug Cotellic (cobimetinib) was approved
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
-
The Kavli Foundation awarded $20 million to establish the Kavli Neuroscience Discovery Institute at The Johns Hopkins University
On Oct. 1, 2015, The Kavli Foundation announced a $20 million award to establish the Kavli Neuroscience Discovery…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
CDC’s Health Alert Network issued health advisory about multi-state outbreak of measles linked to Disneyland
On Jan. 23, 2015, the U.S. Centers for Disease Control and Prevention (CDC) Health Alert Network issued a…
-
Albert Einstein Cancer Center became site for the Hispanic Community Health Study
On Jan. 12, 2015, The Albert Einstein Cancer Center became the only medical institution in New York City,…
-
Agriculture | Biotechnology | Chemistry | Diagnostics | Medical Device | Non-Profit Research | Pharmaceutical | Therapeutics | Veterinary
California Life Sciences Association was founded
In 2015, the California Life Sciences Association was founded. (CLSA) was founded when the Bay Area Bioscience Association…
-
Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Gazyva (obinutuzumab) was approved
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
-
Sea Turtle Genome Revealed Ancient Roadmap of Survival
On Feb. 7, 2023, scientists from the National Oceanic and Atmospheric Administration (NOAA) Fisheries’ tissue library announced they…
-
The UC San Diego Health System acquired the Nevada Cancer Institute
On Jan. 23, 2012, UC San Diego Health System announced it had received approval to acquire the Nevada…
-
Revive & Restore was founded
In 2012, Ryan Phelan and Stewart Brand founded the Revive & Restore project within The Long Now Foundation,…
-
Renowned biochemist Michael A Marletta became president and CEO of The Scripps Research Institute
On Jan 1, 2012, renowned biochemist Michael A. Marletta became president and CEO of The Scripps Research Institute…
-
Biotechnology | Diagnostics | Disease | NIH | Non-Profit Research | Oncology | Therapeutics | Veterinary
The UC Davis Comprehensive Cancer Center received NCI designation
In 2012, The UC Davis Comprehensive Cancer Center received NCI comprehensive cancer designation. The center is a matrix…
-
CALIBR, the California Institute for Biomedical Research, was founded
In 2012, CALIBR, the California Institute for Biomedical Research (Calibr), was launched as a nonprofit translational research institute…
-
The Priestley Medal was awarded to Ahmed H. Zewail
On Mar. 28, 2011, the Priestley Medal was awarded to Ahmed H. Zewail by the American Chemical Society…
-
Stanford Medicine researchers used skin cells from patients with a severe genetic heart defect to create human heart cells with the same genetic mutation
On Feb. 9, 2011, Stanford researchers used skin cells from patients with a severe genetic heart defect to…
-
The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research opened
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
-
Stanford scientists transformed mouse skin cells directly into functional nerve cells with the application of just three genes
On Jan. 27, 2010, scientists at the Stanford University School of Medicine announced they had succeeded in the…
-
New imaging tool can ‘see’ internal body details 1,000X smaller
Apr. 1, 2008, a team of researchers from Stanford’s School of Medicine announced they had developed a new…
-
The Donna and Benjamin M Rosen Bioengineering Center was established at Caltech
In 2008, The Donna and Benjamin Rosen Bioengineering Center was established to use a variety of mechanisms and…
-
UCSF researchers discovered that B cells orchestrate the inflammation of myelin that causes multiple sclerosis
In 2008, University of California, San Francisco (UCSF) researchers discovered that B cells orchestrate the inflammation of myelin…
-
Addario Lung Cancer Medical Institute was founded
In 2008, Addario Lung Cancer Medical Institute was founded as a 501c(3) non-profit organization, is a patient-centric, international…
-
UCSF Cancer Research Institute renamed as tribute to philanthropist Helen Diller
On Nov. 19, 2007, the University of California at San Francisco Cancer (UCSF) Research Institute was renamed the…
-
Stanford researchers found that stem cells transplanted into the brains of rats and mice navigate toward areas damaged by stroke
O Jun. 4, 2007, researchers from the Stanford University School of Medicine announced they had illuminated the path…
-
Livermore Lab developed pathogen signatures for bioterrorist attack Identification
In 2007, researchers at Livermore National Laboratory announced they had developed candidate signatures for pathogens that might be…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
